FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998928167> ?p ?o ?g. }

• W2998928167 endingPage "252" @default.
• W2998928167 startingPage "252" @default.
• W2998928167 abstract "Expanding use of ABO-incompatible kidney transplant (ABOiKT) globally and in India demands harmonized protocols. With an aim to provide unified and standardized consensus for ABOiKT in Indian setting, a 14-member working group formulated this document on key critical areas to guide ABOiKT. The recommendations include the following: (i) Gel column agglutination test is a method of choice for antibody (Ab) titer assessment with tube method as acceptable alternative. Immunoglobulin G measurement is advised for clinical decision making. (ii) Assessment of one Ab titer before subjecting patient to Ab removal is recommended. Postplasmapheresis (PP) titers to be monitored anywhere between 2 and 12 h. (iii) Target Ab titer recommended is ≤1:16 irrespective of the method used for titer assessment. (iv) If cost and availability are not a concern, immunoadsorption (IA) should be preferred. (vi) Choice of replacement fluid depends on the method employed for Ab removal. (vii) Donor or AB-positive plasma transfusion can be considered to avoid coagulopathy and bleeding in posttransplant period. It also decreases the risk of coagulopathy associated with greater number of PP cycles performed during and after transplant. (viii) IA column can be reused if cleaned, sterilized and stored properly. (ix) Intravenous immunoglobulin (IVIG) is optional for use in ABOiKT. Choose IVIG batch with lowest ABO- Ab titers and use in low dose (~ 100 mg/kg). (x) Rituximab in a low dose of 100–200 mg is effective and its use (at-least 2 weeks prior to transplant) is at the discretion of treating renal transplant physician. (xi) Avoid, if possible, the combined used of antithymocyte globulin and rituximab as it increases risk of infections significantly. (xii) Posttransplant PP is needed if there is Ab mediated rejection with increasing titers. (xiii) Standard immunosuppression should be followed. These recommendations are first of a kind that aims to standardize the practice of ABOiKT, serve as a guiding tool to the transplant physicians in India." @default.
• W2998928167 created "2020-01-23" @default.
• W2998928167 creator A5000607778 @default.
• W2998928167 creator A5018614488 @default.
• W2998928167 creator A5033311730 @default.
• W2998928167 creator A5035135714 @default.
• W2998928167 creator A5042266348 @default.
• W2998928167 creator A5051461623 @default.
• W2998928167 creator A5053833894 @default.
• W2998928167 creator A5074033121 @default.
• W2998928167 creator A5078326866 @default.
• W2998928167 creator A5080735819 @default.
• W2998928167 creator A5088455893 @default.
• W2998928167 creator A5091024648 @default.
• W2998928167 creator A5091412782 @default.
• W2998928167 date "2019-01-01" @default.
• W2998928167 modified "2023-10-16" @default.
• W2998928167 title "ABO-incompatible kidney transplantation: Indian working group recommendations" @default.
• W2998928167 cites W1502641477 @default.
• W2998928167 cites W1720974273 @default.
• W2998928167 cites W1750499197 @default.
• W2998928167 cites W1971542954 @default.
• W2998928167 cites W1990478069 @default.
• W2998928167 cites W1998306393 @default.
• W2998928167 cites W2022620519 @default.
• W2998928167 cites W2033562197 @default.
• W2998928167 cites W2052950969 @default.
• W2998928167 cites W2060065995 @default.
• W2998928167 cites W2060348057 @default.
• W2998928167 cites W2061867682 @default.
• W2998928167 cites W2079972225 @default.
• W2998928167 cites W2085916926 @default.
• W2998928167 cites W2092628378 @default.
• W2998928167 cites W2094473847 @default.
• W2998928167 cites W2104343945 @default.
• W2998928167 cites W2111091029 @default.
• W2998928167 cites W2131749577 @default.
• W2998928167 cites W2141769949 @default.
• W2998928167 cites W2142015842 @default.
• W2998928167 cites W2161574301 @default.
• W2998928167 cites W2167496270 @default.
• W2998928167 cites W2171900903 @default.
• W2998928167 cites W2188845683 @default.
• W2998928167 cites W2288773457 @default.
• W2998928167 cites W2465158496 @default.
• W2998928167 cites W2598815890 @default.
• W2998928167 doi "https://doi.org/10.4103/ijot.ijot_39_19" @default.
• W2998928167 hasPublicationYear "2019" @default.
• W2998928167 type Work @default.
• W2998928167 sameAs 2998928167 @default.
• W2998928167 citedByCount "2" @default.
• W2998928167 countsByYear W29989281672022 @default.
• W2998928167 countsByYear W29989281672023 @default.
• W2998928167 crossrefType "journal-article" @default.
• W2998928167 hasAuthorship W2998928167A5000607778 @default.
• W2998928167 hasAuthorship W2998928167A5018614488 @default.
• W2998928167 hasAuthorship W2998928167A5033311730 @default.
• W2998928167 hasAuthorship W2998928167A5035135714 @default.
• W2998928167 hasAuthorship W2998928167A5042266348 @default.
• W2998928167 hasAuthorship W2998928167A5051461623 @default.
• W2998928167 hasAuthorship W2998928167A5053833894 @default.
• W2998928167 hasAuthorship W2998928167A5074033121 @default.
• W2998928167 hasAuthorship W2998928167A5078326866 @default.
• W2998928167 hasAuthorship W2998928167A5080735819 @default.
• W2998928167 hasAuthorship W2998928167A5088455893 @default.
• W2998928167 hasAuthorship W2998928167A5091024648 @default.
• W2998928167 hasAuthorship W2998928167A5091412782 @default.
• W2998928167 hasBestOaLocation W29989281671 @default.
• W2998928167 hasConcept C126322002 @default.
• W2998928167 hasConcept C126894567 @default.
• W2998928167 hasConcept C141071460 @default.
• W2998928167 hasConcept C159654299 @default.
• W2998928167 hasConcept C176080213 @default.
• W2998928167 hasConcept C177713679 @default.
• W2998928167 hasConcept C203014093 @default.
• W2998928167 hasConcept C2776738589 @default.
• W2998928167 hasConcept C2778842783 @default.
• W2998928167 hasConcept C2779839709 @default.
• W2998928167 hasConcept C2779936836 @default.
• W2998928167 hasConcept C2780303639 @default.
• W2998928167 hasConcept C2780653079 @default.
• W2998928167 hasConcept C2911091166 @default.
• W2998928167 hasConcept C32611913 @default.
• W2998928167 hasConcept C71924100 @default.
• W2998928167 hasConcept C89560881 @default.
• W2998928167 hasConceptScore W2998928167C126322002 @default.
• W2998928167 hasConceptScore W2998928167C126894567 @default.
• W2998928167 hasConceptScore W2998928167C141071460 @default.
• W2998928167 hasConceptScore W2998928167C159654299 @default.
• W2998928167 hasConceptScore W2998928167C176080213 @default.
• W2998928167 hasConceptScore W2998928167C177713679 @default.
• W2998928167 hasConceptScore W2998928167C203014093 @default.
• W2998928167 hasConceptScore W2998928167C2776738589 @default.
• W2998928167 hasConceptScore W2998928167C2778842783 @default.
• W2998928167 hasConceptScore W2998928167C2779839709 @default.
• W2998928167 hasConceptScore W2998928167C2779936836 @default.
• W2998928167 hasConceptScore W2998928167C2780303639 @default.
• W2998928167 hasConceptScore W2998928167C2780653079 @default.

• next